Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FH-TCR-TMSLN |
Trade Name | |
Synonyms | FH-TCR TMSLN |
Drug Descriptions |
FH-TCR-TMSLN are autologous T-lymphocytes engineered to express a T-cell receptor (TCR) targeting MSLN, which potentially induce killing of tumor cells expressing MSLN (J Clin Oncol 41, no. 4_suppl (February 01, 2023) TPS779), NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175659 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
FH-TCR-TMSLN | FH-TCR-TMSLN | 0 | 1 |